{"id":"https://openalex.org/W2005236619","doi":"https://doi.org/10.1016/j.bmcl.2013.10.003","title":"Drug discovery considerations in the development of covalent inhibitors","display_name":"Drug discovery considerations in the development of covalent inhibitors","publication_year":2013,"publication_date":"2013-10-10","ids":{"openalex":"https://openalex.org/W2005236619","doi":"https://doi.org/10.1016/j.bmcl.2013.10.003","mag":"2005236619","pmid":"https://pubmed.ncbi.nlm.nih.gov/24314671"},"language":"en","primary_location":{"id":"doi:10.1016/j.bmcl.2013.10.003","doi":"https://doi.org/10.1016/j.bmcl.2013.10.003","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2013.10.003","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005236619"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Robert Mah","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4400600974","display_name":"Novartis Institutes for BioMedical Research","ror":"https://ror.org/053gv2m95","country_code":"CH","type":"funder","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4400600974"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Robert Mah","raw_affiliation_strings":["Global Discovery Chemistry/Oncology & Exploratory Chemistry, Novartis Institutes for Biomedical Research, Klybeckstrasse 141, CH-4057 Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Discovery Chemistry/Oncology & Exploratory Chemistry, Novartis Institutes for Biomedical Research, Klybeckstrasse 141, CH-4057 Basel, Switzerland","institution_ids":["https://openalex.org/I4400600974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041835523","display_name":"Jason R. Thomas","orcid":"https://orcid.org/0000-0001-7502-3600","observed_orcids":["https://orcid.org/0000-0001-7502-3600"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jason R. Thomas","raw_affiliation_strings":["Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA","Developmental & Molecular Pathways, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Developmental and Molecular Pathways, Novartis Institutes for Biomedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA","institution_ids":[]},{"raw_affiliation_string":"Developmental & Molecular Pathways, Novartis Institutes for BioMedical Research, 250 Massachusetts Avenue, Cambridge, MA 02139, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085050249","display_name":"Cynthia M. Shafer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Cynthia M. Shafer","raw_affiliation_strings":["Global Discovery Chemistry/Oncology & Exploratory Chemistry, Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, CA 94608, USA. Electronic address: cynthia.shafer@novartis.com","Global Discovery Chemistry/Oncology and Exploratory Chemistry, Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, CA 94608, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Global Discovery Chemistry/Oncology & Exploratory Chemistry, Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, CA 94608, USA. Electronic address: cynthia.shafer@novartis.com","institution_ids":[]},{"raw_affiliation_string":"Global Discovery Chemistry/Oncology and Exploratory Chemistry, Novartis Institutes for Biomedical Research, 4560 Horton Street, Emeryville, CA 94608, USA","institution_ids":["https://openalex.org/I4210117619"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5085050249"],"corresponding_institution_ids":["https://openalex.org/I4210117619"],"apc_list":{"value":3880,"currency":"USD","value_usd":3880},"apc_paid":null,"fwci":1.2071,"has_fulltext":false,"cited_by_count":204,"citation_normalized_percentile":{"value":0.75435203,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":98,"max":100},"biblio":{"volume":"24","issue":"1","first_page":"33","last_page":"39"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11440","display_name":"Click Chemistry and Applications","score":0.36739999055862427,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11440","display_name":"Click Chemistry and Applications","score":0.36739999055862427,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12412","display_name":"Enzyme function and inhibition","score":0.10729999840259552,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.07360000163316727,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/covalent-inhibitors","display_name":"covalent inhibitors","score":0.9980000257492065},{"id":"https://openalex.org/keywords/drug-discovery","display_name":"drug discovery","score":0.8289999961853027},{"id":"https://openalex.org/keywords/covalent-drug-design","display_name":"covalent drug design","score":0.5690000057220459},{"id":"https://openalex.org/keywords/inhibitor-optimization","display_name":"inhibitor optimization","score":0.7870000004768372},{"id":"https://openalex.org/keywords/clinical-drug-candidates","display_name":"clinical drug candidates","score":0.4259999990463257}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6808974742889404},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.6408158540725708},{"id":"https://openalex.org/C180577832","wikidata":"https://www.wikidata.org/wiki/Q127920","display_name":"Covalent bond","level":2,"score":0.5574395060539246},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5518737435340881},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.5330556631088257},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5040935277938843},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.3424145579338074},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.32918110489845276},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14604869484901428},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.1339971125125885},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.05666795372962952},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000138","qualifier_name":"chemical synthesis","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D004798","descriptor_name":"Enzymes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.bmcl.2013.10.003","doi":"https://doi.org/10.1016/j.bmcl.2013.10.003","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.bmcl.2013.10.003","pdf_url":null,"source":{"id":"https://openalex.org/S30970080","display_name":"Bioorganic & Medicinal Chemistry Letters","issn_l":"0960-894X","issn":["0960-894X","1464-3405"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & Medicinal Chemistry Letters","raw_type":"journal-article"},{"id":"pmid:24314671","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24314671","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Bioorganic & medicinal chemistry letters","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":63,"referenced_works":["https://openalex.org/W1563650227","https://openalex.org/W1575019839","https://openalex.org/W1964862845","https://openalex.org/W1968642738","https://openalex.org/W1972891035","https://openalex.org/W1976264236","https://openalex.org/W1976376430","https://openalex.org/W1977565331","https://openalex.org/W1982429227","https://openalex.org/W1986069028","https://openalex.org/W1988138188","https://openalex.org/W1999587831","https://openalex.org/W1999822411","https://openalex.org/W2001462701","https://openalex.org/W2002355116","https://openalex.org/W2007139310","https://openalex.org/W2010993054","https://openalex.org/W2014349456","https://openalex.org/W2016885943","https://openalex.org/W2019792957","https://openalex.org/W2021790986","https://openalex.org/W2026542427","https://openalex.org/W2027891229","https://openalex.org/W2028159862","https://openalex.org/W2034375022","https://openalex.org/W2036000997","https://openalex.org/W2049334204","https://openalex.org/W2052035095","https://openalex.org/W2057079741","https://openalex.org/W2057315451","https://openalex.org/W2065108839","https://openalex.org/W2069685762","https://openalex.org/W2071648775","https://openalex.org/W2074692351","https://openalex.org/W2074730236","https://openalex.org/W2074753679","https://openalex.org/W2077804275","https://openalex.org/W2082622773","https://openalex.org/W2083266527","https://openalex.org/W2088659758","https://openalex.org/W2095513663","https://openalex.org/W2097817246","https://openalex.org/W2106462471","https://openalex.org/W2106913324","https://openalex.org/W2107344789","https://openalex.org/W2111567427","https://openalex.org/W2114163388","https://openalex.org/W2114869204","https://openalex.org/W2119177802","https://openalex.org/W2138536086","https://openalex.org/W2138851777","https://openalex.org/W2145186618","https://openalex.org/W2149567364","https://openalex.org/W2153977062","https://openalex.org/W2160401113","https://openalex.org/W2163690533","https://openalex.org/W2167854315","https://openalex.org/W2285120364","https://openalex.org/W2313705799","https://openalex.org/W2320793684","https://openalex.org/W2332803613","https://openalex.org/W2523153670","https://openalex.org/W4241363254"],"related_works":["https://openalex.org/W2622009965","https://openalex.org/W3158513244","https://openalex.org/W4407683774","https://openalex.org/W4380301919","https://openalex.org/W4405819339","https://openalex.org/W2796108867","https://openalex.org/W4399992662","https://openalex.org/W3038238188","https://openalex.org/W4388289629","https://openalex.org/W3093091145"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":11},{"year":2022,"cited_by_count":14},{"year":2021,"cited_by_count":17},{"year":2020,"cited_by_count":22},{"year":2019,"cited_by_count":12},{"year":2018,"cited_by_count":16},{"year":2017,"cited_by_count":22},{"year":2016,"cited_by_count":36},{"year":2015,"cited_by_count":21},{"year":2014,"cited_by_count":7}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}